Powerful insights ahead!🎙️ Tune in as we explore perspectives from people with #SMA on the critical changes needed for adults living with this rare disease in Europe. Don't miss the latest episode of the #SMAMyWay podcast. 💬✨ spkl.io/601747hYd

#MEDIA We’re happy to announce late-breaking data at #ASRS2024 from the long-term study of our bispecific antibody for the treatment of DME - welcome news for the millions of people at risk of #VisionLoss. spkl.io/60194CrS5 $ROG $RHHBY

#MEDIA We’re proud to present new two-year data on two serious diabetic eye conditions for our refillable eye implant at #ASRS2024. Additionally, the US FDA has accepted our application for the potential approval of the implant in these conditions. roche.com/media/releases… $ROG

Roche sales increase by 5% (CER) in first half of 2024; strong growth in second quarter – full-year earnings outlook raised. For more details on our performance, click here ➡️ spkl.io/60114CQdd $ROG $RHHBY #RocheFinancialResults

🚀 We are driving innovation for those living with #AlzheimersDisease! Our commitment to advancing diagnostics and new therapies shows our dedication to every aspect of the patient journey. 🧠💙 Discover more scientific advancements 👉 spkl.io/60184CvfY #RocheInnovation

We are pleased to announce today the completion of the acquisition of LumiraDx’s Point of Care diagnostics technology, enabling us to expand patient access to timely diagnostics results in decentralised healthcare settings worldwide. $ROG $RHHBY ➡️ spkl.io/60164CC6G

#MEDIA Our bispecific antibody has received approval from the European Commission for the treatment of macular edema secondary to retinal vein occlusion (RVO)–furthering our mission to save people’s sight from the leading causes of #VisionLoss. spkl.io/60114h8iv $ROG $RHHBY

🎙️ New episode live! Listen to the latest instalment of the #SMAMyWay podcast to hear Martyn and Josh discuss travel and access and how #disability can affect them both ✈️ spkl.io/60104hMPi

The average time for people to receive a lung cancer diagnosis after first noticing symptoms is often more than 6 months. This delay can impact treatment options and outcomes. If you notice any persistent symptoms, don’t wait. Talk to your doctor and get checked early.

#MEDIA — We are supporting World Health Organization (WHO) declaration of a global health emergency due to the ongoing #mpox outbreak with diagnostic tests developed for mpox, formerly known as #monkeypox. Learn more: spkl.io/6018f6pRy $ROG $RHHBY

🌟Scientists from #TeamIHB and Roche #pRED have made an exciting discovery that could help to better predict a drug’s effect on the body.🌟 🔬Significant research now published in nature.🚀 🎉 Check it out spkl.io/6013f6wcD #RocheInnovation Institute of Human Biology

XProject is joining forces to advance women's health. Our partnerships are reshaping global healthcare, breaking barriers and fostering meaningful change. Learn more spkl.io/6010f69ga about our initiatives for healthcare equality #TogetherForChange #XProject #Partnerships

#MEDIA – We are pleased to announce that the European Commission has approved our treatment for paroxysmal nocturnal haemoglobinuria in the EU. Learn more: spkl.io/6012f6xoo $ROG $RHHBY #PNH

This week, we will follow our colleague Elisa as she is “Walking the Talk for Dementia” across the Camino de Santiago and sharing her unique experiences. We at Roche are dedicated to stopping #Alzheimers and dementia in its tracks. Be part of this journey. #dementia

Through local partnerships and diverse collaborations, we're dedicated to ensuring that women receive the treatment, diagnosis and care they deserve. Learn more spkl.io/6016f6hJr how we create a lasting impact in healthcare. #TogetherForChange #XProject #Partnerships

After an emotional four-day journey, our colleague Elisa and fellow dementia fighters reached Santiago de Compostela. Elisa met with Fernando Aguzzoli-Peres to share reflections on the "Walking the Talk for Dementia". #Alzheimers #AtlanticFellows

🎙️ Listen to the newest episode of the #SMAMyWay Podcast where Martyn and Josh discuss entrepreneurship and success and how #disability can affect them both! ✨ spkl.io/6010fBzOO #SMA

Roche and SAS Brasil are joining forces to provide holistic solutions and better cervical cancer outcomes for women in Brazil. Learn more spkl.io/6013fBdt3 #TogetherForChange #Partnerships #XProject